MS (2023. 3-2025. 1)
3. Jeong, D., Kim, J., Kim, Y., Jun, H., Eom, S., and Kang, S.,* HER2-targeting and TRAIL-presenting Protein Nanoparticles Induce a Concentration-Dependent Biphasic Response in HER2-Positive Breast Cancer Cells. Biomacromolecules, 2026, Accepted.
2. Jun, H., Kim, J., Eom, S., Jeong, D., and Kang, S.,* Targeted Therapy for CD13-overexpressing Triple-Negative Breast Cancers Using Apoptosis-inducing Protein Cage Nanoparticles. Macromol. Biosci. 2026, 26, e00645.
1. Kim, Y.,* Kim, J., Eom, S., Jun, H., Lee, H. B., Jeong, D., and Kang, S.,* Protein Nanoparticles Simultaneously Displaying TRAIL and EGFR-Binding Ligands Effectively Induce Apoptotic Cancer Cell Death and Overcome EGFR-TKI Resistance in Lung Cancer. ACS Appl. Mater. Interfaces, 2025, 17, 25139-25151..